Total Payments
$399.68
2021 Payments
$87.06
Companies
7
Transactions
20
Medicare Patients
61,473
Medicare Billing
$6.8M
Payment Breakdown by Category
Food & Beverage$300.68 (75.2%)
Education$99.00 (24.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $300.68 | 19 | 75.2% |
| Education | $99.00 | 1 | 24.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $120.25 | 8 | $0 (2020) |
| Kite Pharma, Inc. | $102.63 | 6 | $0 (2021) |
| Amgen Inc. | $99.00 | 1 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $38.42 | 2 | $0 (2018) |
| Epizyme, Inc., | $14.74 | 1 | $0 (2021) |
| Spectrum Pharmaceuticals Inc. | $13.39 | 1 | $0 (2017) |
| Kyowa Kirin, Inc. | $11.25 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $87.06 | 5 | Kite Pharma, Inc. ($72.32) |
| 2020 | $41.99 | 3 | Kite Pharma, Inc. ($30.31) |
| 2019 | $42.32 | 3 | Novartis Pharmaceuticals Corporation ($31.07) |
| 2018 | $99.30 | 6 | Novartis Pharmaceuticals Corporation ($60.88) |
| 2017 | $129.01 | 3 | Amgen Inc. ($99.00) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/08/2021 | Epizyme, Inc., | TAZVERIK (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2021 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $17.68 | General |
| 06/22/2021 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $19.87 | General |
| 05/07/2021 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $17.28 | General |
| 02/22/2021 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $17.49 | General |
| 11/04/2020 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug) | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: ONCOLOGY | ||||||
| 11/03/2020 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $14.54 | General |
| 08/31/2020 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $15.77 | General |
| 07/09/2019 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug), TASIGNA | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: ONCOLOGY | ||||||
| 02/20/2019 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: ONCOLOGY | ||||||
| 02/07/2019 | Kyowa Kirin, Inc. | SANCUSO (Drug), POTELIGEO | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: ANTIEMETIC - 5HT3 INHIBITOR | ||||||
| 11/09/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $26.76 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/30/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/09/2018 | Novartis Pharmaceuticals Corporation | RECLAST (Drug) | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: BONE | ||||||
| 02/26/2018 | Novartis Pharmaceuticals Corporation | RYDAPT (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: HEMATOLOGY | ||||||
| 01/31/2018 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: ONCOLOGY | ||||||
| 01/09/2018 | Novartis Pharmaceuticals Corporation | JADENU (Drug), PROMACTA | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: HEMATOLOGY | ||||||
| 10/31/2017 | Novartis Pharmaceuticals Corporation | RYDAPT (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: HEMATOLOGY | ||||||
| 10/25/2017 | Spectrum Pharmaceuticals Inc. | Zevalin (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Not Applicable | ||||||
| 05/09/2017 | Amgen Inc. | — | Education | In-kind items and services | $99.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 87 | 14,016 | 122,785 | $6.1M | $1.1M |
| 2022 | 111 | 17,034 | 282,896 | $11.1M | $2.1M |
| 2021 | 98 | 16,851 | 304,028 | $12.2M | $2.2M |
| 2020 | 89 | 13,572 | 147,034 | $8.4M | $1.4M |
Total Patients
61,473
Total Services
856,743
Medicare Billing
$6.8M
Procedure Codes
385
All Medicare Procedures & Services
385 procedure records from CMS Medicare Utilization — Page 15 of 16
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 86304 | Immunologic analysis for detection of tumor antigen | Office | 2020 | 22 | 73 | $3,650 | $1,509 | 41.3% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis | Office | 2020 | 24 | 63 | $4,725 | $1,304 | 27.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 63 | 64 | $2,560 | $1,263 | 49.3% |
| J1756 | Injection, iron sucrose, 1 mg | Office | 2020 | 22 | 7,000 | $105,000 | $1,143 | 1.1% |
| 82232 | Beta-2 microglobulin (protein) level | Office | 2020 | 53 | 71 | $2,840 | $1,126 | 39.6% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 39 | 50 | $5,000 | $1,033 | 20.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 14 | 15 | $2,350 | $1,004 | 42.7% |
| 82105 | Alpha-fetoprotein (afp) level, serum | Office | 2020 | 26 | 58 | $2,320 | $964.16 | 41.6% |
| 96402 | Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle | Office | 2020 | 12 | 26 | $3,120 | $797.52 | 25.6% |
| 83010 | Haptoglobin (serum protein) level | Office | 2020 | 49 | 58 | $4,350 | $725.39 | 16.7% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2020 | 13 | 17 | $2,550 | $695.12 | 27.3% |
| 84439 | Thyroxine (thyroid chemical) measurement | Office | 2020 | 40 | 60 | $1,800 | $537.06 | 29.8% |
| 85610 | Blood test, clotting time | Office | 2020 | 47 | 121 | $3,630 | $515.22 | 14.2% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation | Office | 2020 | 94 | 121 | $2,420 | $512.26 | 21.2% |
| 86141 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2020 | 31 | 34 | $1,700 | $424.75 | 25.0% |
| 85044 | Red blood count, manual test | Office | 2020 | 66 | 87 | $870.00 | $368.68 | 42.4% |
| J9045 | Injection, carboplatin, 50 mg | Office | 2020 | 14 | 147 | $7,350 | $312.08 | 4.2% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2020 | 84 | 215 | $2,150 | $311.27 | 14.5% |
| 87880 | Strep test (streptococcus, group a) | Office | 2020 | 15 | 17 | $1,105 | $280.35 | 25.4% |
| J7030 | Infusion, normal saline solution , 1000 cc | Office | 2020 | 49 | 132 | $1,320 | $254.75 | 19.3% |
| 81000 | Manual urinalysis test with examination using microscope | Office | 2020 | 36 | 61 | $610.00 | $242.98 | 39.8% |
| 93793 | Anti-clotting management for patient taking warfarin | Office | 2020 | 14 | 24 | $2,400 | $207.59 | 8.6% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 18 | 21 | $1,050 | $202.77 | 19.3% |
| 82247 | Bilirubin level | Office | 2020 | 35 | 36 | $540.00 | $179.82 | 33.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2020 | 13 | 13 | $3,900 | $173.53 | 4.4% |
About Dr. Gurmohan Syali, MD
Dr. Gurmohan Syali, MD is a Medical Oncology healthcare provider based in E Setauket, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1932195138.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gurmohan Syali, MD has received a total of $399.68 in payments from pharmaceutical and medical device companies, with $87.06 received in 2021. These payments were reported across 20 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($300.68).
As a Medicare-enrolled provider, Syali has provided services to 61,473 Medicare beneficiaries, totaling 856,743 services with total Medicare billing of $6.8M. Data is available for 4 years (2020–2023), covering 385 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical Oncology
- Location E Setauket, NY
- Active Since 09/22/2005
- Last Updated 03/24/2014
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1932195138
Products in Payments
- XARELTO (Drug) $38.42
- RYDAPT (Drug) $36.13
- KISQALI (Drug) $30.64
- JADENU (Drug) $16.16
- TAZVERIK (Drug) $14.74
- Zevalin (Drug) $13.39
- PROMACTA (Drug) $13.34
- RECLAST (Drug) $12.30
- PIQRAY (Drug) $11.68
- SANCUSO (Drug) $11.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.